Enhancement of immune responses by 4-1bb-binding agents
US7651686B2 · kind B2 · utility
33Cited by
1References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2002 |
| Grant date | Jan 26, 2010 |
| Priority date | — |
| Expiry date | Mar 28, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention features methods of enhancing immune responses in mammalian subjects and in vitro methods of enhancing the response of a T cell. Also embodied by the invention are methods of receiving and preventing the induction of energy in T cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.